Tertroxin 20 Μg 20 μg Tablet.
PDF Leaflet Revision Date: 02 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of myxoedema coma and severe chronic thyroid deficiency.
Dosage (summary)
Adults: Start with 10-20 u03bcg, increase to 80-100 u03bcg daily. Elderly: Start with 5 u03bcg daily.
Special Populations
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Limited placental transfer; excreted in breast milk.
Key Drug Interactions
- Anticoagulants
- Anticonvulsants
- Aspirin
- Oral contraceptives
Contraindications
- Hypersensitivity to liothyronine
- Cardiovascular disorders
- Untreated adrenal insufficiency
- Untreated hyperthyroidism
Common side effects
- Anginal pain
- Palpitations
- Headache
- Muscle cramps
Counselling Points
- Report chest pain or palpitations
- Monitor thyroid status regularly
- Avoid use in obesity management
Serious warnings
- Caution in endocrine disorders
- Risk of precipitating hyperthyroid state
- Monitor for cardiac dysrhythmias
Important Disclaimer
The Tertroxin 20 Μg 20 μg Tablet. professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
